Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
Breast Cancer Update
00:00
Exploring Efficacy, Toxicity, and Targeted Therapies in Breast Cancer: Insights from Clinical Trials
Exploring the differences in efficacy and toxicity of oral SERDs for breast cancer treatment, focusing on patient outcomes, mutation profiles, resistance factors, and the impact of targeted therapies like alpelisib and capiva SERD. Detailed review of the Phase III Capatella 291 study discussing patient criteria, treatment arms, dosing schedules, and key results.
Play episode from 46:38
Transcript
